VMD
Viemed Healthcare Inc
9.10$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.5% | 58.7% | 45.4% | 45.1% | 43.1% | 33.7% | 41.9% | 40.1% | 34.0% | 24.8% | 29.9% | 22.6% | |
| 16.1% | 14.0% | 17.6% | 13.5% | 19.5% | 16.2% | 27.5% | 24.1% | 14.5% | 8.3% | 9.9% | 6.3% | |
| 16.1% | 14.0% | 17.6% | 13.5% | 19.5% | 16.2% | 27.5% | 24.1% | 14.5% | 8.3% | 9.9% | 6.3% | |
| 48.0% | 35.9% | 19.4% | 26.0% | 16.5% | 14.0% | 11.0% | 12.5% | 13.2% | 11.9% | 14.1% | 11.9% | |
| 7.7% | 6.8% | 6.6% | 4.3% | 5.4% | 1.6% | 2.1% | 2.1% | 3.1% | 3.0% | 2.4% | 2.3% | |
| – | 41.3% | 54.6% | 54.9% | 57.1% | 66.3% | 48.9% | 53.3% | 58.5% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | 19.2% | 18.6% | 27.4% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 0.4% | 0.5% | 0.6% | |
| 16.9% | 48.0% | 47.8% | 37.0% | 39.4% | 47.1% | 27.4% | 19.6% | 17.0% | 26.5% | 24.7% | 33.2% | |
| 16.9% | 37.3% | 37.1% | 34.9% | 36.6% | 31.4% | 20.4% | 15.1% | 16.1% | 20.7% | 21.1% | 19.1% | |
| 7.0% | 16.6% | 15.6% | 11.6% | -4.3% | 10.7% | 4.1% | 1.6% | 0.4% | 1.3% | 0.7% | 1.1% | |
| 7.4% | 3.9% | 7.6% | 9.0% | 11.0% | 6.9% | 3.0% | 4.5% | 4.2% | 4.8% | 5.3% | 5.7% | |
| – | 2.1% | 0.0% | 0.0% | 0.0% | 9.2% | 5.1% | 3.7% | – | 3.9% | 2.0% | 5.3% | |
| 83.1% | 52.0% | 52.2% | 63.0% | 65.5% | 52.9% | 72.6% | 80.4% | 83.0% | 73.5% | 74.2% | 65.9% | |
| 82.4% | 51.7% | 51.9% | 55.7% | 55.2% | 41.3% | 58.3% | 62.2% | 59.7% | 51.3% | 50.7% | 47.9% | |
| 59.1% | 26.8% | 153.6% | 100.7% | 74.1% | 48.1% | 36.0% | 34.5% | 34.0% | 26.1% | 23.0% | 19.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.